These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10340832)

  • 41. Digoxin toxicity treated with Digibind.
    Schakenbach L; Arft P
    Crit Care Nurse; 1989 May; 9(5):16-22. PubMed ID: 2805742
    [No Abstract]   [Full Text] [Related]  

  • 42. Experience with digoxin immune Fab (ovine) in patients with renal impairment.
    Wenger TL
    Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):21-3; discussion 33-4. PubMed ID: 1997017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of non-digitalis binding properties of digoxin-specific Fabs using direct binding methods.
    Pullen MA; Harpel MR; Danoff TM; Brooks DP
    J Immunol Methods; 2008 Jul; 336(2):235-41. PubMed ID: 18555269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of assay methods on serum concentrations of digoxin during FAB fragment treatment.
    Banner W; Bach P; Burk B; Freestone S; Gooch WM
    J Toxicol Clin Toxicol; 1992; 30(2):259-67. PubMed ID: 1588675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Digitalis-like and vasoconstrictor effects of endogenous digoxin-like factor(s) from the venom of Bufo marinus toad.
    Bagrov AY; Roukoyatkina NI; Fedorova OV; Pinaev AG; Ukhanova MV
    Eur J Pharmacol; 1993 Apr; 234(2-3):165-72. PubMed ID: 8387009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Digoxin and digoxin derivative induced arrhythmias: in vitro binding and in vivo abolition of arrhythmias by digoxin immune Fab (DIGIBAND).
    Cambridge D; Morgan CR; Allen G
    Cardiovasc Res; 1992 Sep; 26(9):906-11. PubMed ID: 1451168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recurrent digoxin overdose and treatment with digoxin-specific Fab antibody fragments.
    Bosse GM; Pope TM
    J Emerg Med; 1994; 12(2):179-85. PubMed ID: 8207153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children.
    Woolf AD; Wenger T; Smith TW; Lovejoy FH
    N Engl J Med; 1992 Jun; 326(26):1739-44. PubMed ID: 1594015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activated charcoal is more effective than equilibrium dialysis in removing Chinese medicines Chan Su and Dan Shen from serum and activated charcoal also prevents further absorption of these agents from G.I. tract in mice: monitoring the effect in clinical laboratory by measuring digoxin activity in serum.
    Dasgupta A; Wahed A; Culton L; Olsen M; Wells A; Actor JK
    Clin Chim Acta; 2002 Oct; 324(1-2):51-9. PubMed ID: 12204425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of digoxin-specific antibody Fab fragment (Digibind) on blood pressure and renal water-sodium metabolism in 5/6 reduced renal mass hypertensive rats.
    Kaide J; Ura N; Torii T; Nakagawa M; Takada T; Shimamoto K
    Am J Hypertens; 1999 Jun; 12(6):611-9. PubMed ID: 10371371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).
    Chan BS; Isbister GK; O'Leary M; Chiew A; Buckley NA
    Clin Toxicol (Phila); 2016 Jul; 54(6):488-94. PubMed ID: 27118413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Correlative study of bufogenin constituents in venom of Bufo bufo gargarizans].
    Cao YT; Cui KK; Wu JH; Pan HY; Lu ZY; Shao JF; Wang LH
    Zhongguo Zhong Yao Za Zhi; 2019 May; 44(9):1850-1856. PubMed ID: 31342712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study.
    Hickey AR; Wenger TL; Carpenter VP; Tilson HH; Hlatky MA; Furberg CD; Kirkpatrick CH; Strauss HC; Smith TW
    J Am Coll Cardiol; 1991 Mar; 17(3):590-8. PubMed ID: 1993775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electrophysiologic similarities of overdose between digoxin and bufadienolides found in a Chinese aphrodisiac.
    Bressman M; Repplinger D; Slater W; Patt M
    J Arrhythm; 2017 Feb; 33(1):76-78. PubMed ID: 28217235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Study on quality standard of Bufonis Venenum and its processed slice, toad venom powder].
    Fang YG; Wang PF; Zhu HD; Chen LM; Wang ZM; Gao HM; Fu XT; Nie J
    Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(8):1726-1733. PubMed ID: 32489055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The monitoring of plasma digoxin levels during acute digitalis poisoning treated with Fab anti-digoxin fragments].
    Milani L; Bizzaro N; Sanson A
    G Ital Cardiol; 1992 Jan; 22(1):97-101. PubMed ID: 1624074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring serum digoxin concentrations during digoxin immune Fab therapy.
    Ujhelyi MR; Colucci RD; Cummings DM; Green PJ; Robert S; Vlasses PH; Zarowitz BJ
    DICP; 1991 Oct; 25(10):1047-9. PubMed ID: 1803787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical experience with titrating doses of digoxin antibodies in acute digoxin poisoning. (ATOM-6).
    Chan BS; Isbister GK; Chiew A; Isoardi K; Buckley NA
    Clin Toxicol (Phila); 2022 Apr; 60(4):433-439. PubMed ID: 34424803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Digoxinlike toxicity and death from a purported aphrodisiac.
    Pierach CA
    JAMA; 1996 Apr; 275(13):988. PubMed ID: 8596255
    [No Abstract]   [Full Text] [Related]  

  • 60. Plant cardiac glycosides and digoxin Fab antibody.
    Cheung K; Urech R; Taylor L; Duffy P; Radford D
    J Paediatr Child Health; 1991 Oct; 27(5):312-3. PubMed ID: 1931226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.